Aytu BioScience (AYTU)

0.88 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/8/18 *Est.)

Latest Headlines

Investor Expectations to Drive Momentum within ANGI Homeservices, Aytu Bioscience, IRIDEX, Cellular Biomedicine Group, CounterPath, and EXFO — Discovering Underlying Factors of Influence November 16, 2018 8:50 AM - Globe NewsWire Aytu BioScience (AYTU) Reports Positive Interim Results from Natesto Spermatogenesis Study November 15, 2018 8:10 AM - StreetInsider Aytu BioScience Announces Positive Interim Results from Natesto(R) Spermatogenesis Study November 15, 2018 8:07 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Nov 15 November 15, 2018 8:06 AM - SEC Filing Aytu BioScience to Report Interim Results from Natesto(R) Spermatogenesis Study on Thursday, November 15, 2018 November 13, 2018 8:07 AM - StreetInsider Form 10-Q AYTU BIOSCIENCE, INC For: Sep 30 November 7, 2018 4:11 PM - SEC Filing Form 8-K AYTU BIOSCIENCE, INC For: Nov 07 November 7, 2018 4:03 PM - SEC Filing Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio November 7, 2018 4:03 PM - StreetInsider Aytu BioScience (AYTU) Announces Exclusive Licence Agreement with Tris Pharma for Tuzistra; Armistice Capital Provides $5M Strategic Investment to Accelerate Tuzistra Growth November 5, 2018 8:14 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Nov 02 November 5, 2018 8:07 AM - SEC Filing Aytu BioScience Enters $3 Billion Cough and Cold Market and Expands Primary Care Portfolio, with Exclusive U.S. Licensing of Revenue-Generating, FDA-Approved Antitussive Tuzistra(R) XR November 5, 2018 8:07 AM - StreetInsider Aytu BioScience to Report Fiscal First Quarter 2019 Results and Business Update October 31, 2018 8:13 AM - StreetInsider Form 4 AYTU BIOSCIENCE, INC For: Oct 24 Filed by: DOCKERY CARL October 29, 2018 1:28 PM - SEC Filing Form 4 AYTU BIOSCIENCE, INC For: Oct 24 Filed by: MACALUSO MICHAEL October 26, 2018 7:58 PM - SEC Filing Form 4 AYTU BIOSCIENCE, INC For: Oct 24 Filed by: Green David A October 26, 2018 7:57 PM - SEC Filing Form 4 AYTU BIOSCIENCE, INC For: Oct 24 Filed by: Donofrio John Jr. October 26, 2018 7:55 PM - SEC Filing Form 4 AYTU BIOSCIENCE, INC For: Oct 24 Filed by: Disbrow Joshua R. October 26, 2018 7:50 PM - SEC Filing Form 4 AYTU BIOSCIENCE, INC For: Oct 24 Filed by: Disbrow Jarrett October 26, 2018 7:49 PM - SEC Filing Form 4 AYTU BIOSCIENCE, INC For: Oct 24 Filed by: Cantrell Gary October 26, 2018 7:48 PM - SEC Filing Form 8-K AYTU BIOSCIENCE, INC For: Oct 22 October 22, 2018 8:31 AM - SEC Filing Northland Capital Markets Starts Aytu Biosciences (AYTU) at Outperform October 22, 2018 7:30 AM - StreetInsider Form SC 13G AYTU BIOSCIENCE, INC Filed by: CVI Investments, Inc. October 12, 2018 8:52 AM - SEC Filing UPDATE: Aytu BioScience (AYTU) Secures 1st U.S. Patent Covering MiOXSYS for Male Infertility October 11, 2018 8:16 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Oct 11 October 11, 2018 8:06 AM - SEC Filing Aytu BioScience Announces Issuance of First U.S. Patent Covering MiOXSYS(R) for Male Infertility; Company Progresses Toward U.S. Regulatory Clearance and Commercialization October 11, 2018 8:06 AM - StreetInsider Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option October 10, 2018 8:07 AM - StreetInsider Form 424B4 AYTU BIOSCIENCE, INC October 5, 2018 5:45 PM - SEC Filing Aytu BioScience (AYTU) Prices $13.2M Common Share Offering October 5, 2018 8:33 AM - StreetInsider Aytu BioScience Announces Pricing of $13.2 Million Underwritten Public Offering October 5, 2018 8:31 AM - StreetInsider Form EFFECT AYTU BIOSCIENCE, INC October 5, 2018 6:02 AM - SEC Filing Form S-1MEF AYTU BIOSCIENCE, INC October 4, 2018 8:24 PM - SEC Filing Form S-1/A AYTU BIOSCIENCE, INC October 3, 2018 4:17 PM - SEC Filing Aytu BioScience (AYTU) gains following granting of U.S patent October 2, 2018 1:51 PM - StreetInsider Form FWP AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC September 28, 2018 4:18 PM - SEC Filing Form S-1/A AYTU BIOSCIENCE, INC September 28, 2018 4:10 PM - SEC Filing Form S-1/A AYTU BIOSCIENCE, INC September 25, 2018 4:13 PM - SEC Filing Aytu BioScience (AYTU) Reports Publication of Manuscript Summarizing Results from the Ongoing Natesto Spermatogenesis Study September 17, 2018 8:27 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Sep 17 September 17, 2018 8:08 AM - SEC Filing Aytu BioScience Announces Publication of Manuscript Summarizing Results from the Ongoing Natesto(R) Spermatogenesis Study September 17, 2018 8:07 AM - StreetInsider Acerus Announces Publication of Manuscript Reporting Early Data from Partner-Sponsored Natesto® Spermatogenesis Study September 17, 2018 7:01 AM - BizWire Form S-1 AYTU BIOSCIENCE, INC September 7, 2018 5:24 PM - SEC Filing Form 10-K AYTU BIOSCIENCE, INC For: Jun 30 September 6, 2018 4:34 PM - SEC Filing Form 8-K AYTU BIOSCIENCE, INC For: Sep 06 September 6, 2018 4:07 PM - SEC Filing Natesto(R) Q4 Revenue Increases 178% Sequentially; Q4 Product Revenue Increases 52% Sequentially September 6, 2018 4:04 PM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Aug 30 August 30, 2018 8:31 AM - SEC Filing Aytu BioScience to Report Fiscal Fourth Quarter 2018 Results and Business Update August 30, 2018 8:09 AM - StreetInsider Full Article List